· Pharmaceutical
· Pharmacokinetic
· Pharmacodynamics
Impurities |
· Manufactured by superheating NH4NO3 to 250°C · Products: N2O plus NH3, N2, NO, NO2 · Removal of impurities by scrubbers may be incomplete o e.g. NO2: airway damage, headache, heart failure |
Storage |
· Need to reduce filling ratio from 0.75 to 0.67 in hot climates |
Entonox lamination |
· Occurs below pseudocritical temperature (~-6°C) · Results in delivery of hyperoxic then hypoxic mixture |
Supports combustion |
· Like O2 · Not itself flammable |
Absorption |
· N/A, concentration effect beneficial |
Distribution |
· N2O 30x more soluble, BGPC 0.47; diffuses rapidly into air spaces · N2 30x less soluble, BGPC 0.014; diffuses slowly from air spaces · Hence expansion of existing closed air spaces o ↑size pneumothorax o ↑Bowel gas -> difficult laparoscopy o ↑Ocular gas (of ocular surgery with SF6?) o ↑Pneumocephalus (if brain surgery) |
Metabolism |
· Minimal, 0.004% |
Excretion |
Diffusion hypoxia: · Reverse of the concentration effect · Switch from N2O/O2 to N2/O2 · Rapid output N2O into alveolus, but very slow uptake of N2 · Dilution of alveolar O2 -> hypoxia · Avoided by high %O2 during washout |
Cardiovascular |
· Direct: ↓heart rate, ↓contractility, ↓SVR · Via ↑SNS output: ↑HR, ↑contractility, ↑SVR |
Respiratory |
· ↑RR, ↓TV · ↑SNS output -> ↑PVR -> ↑RV strain |
CNS |
· MAC 105%, MAC-awake 67%; cannot be used alone as anaesthetic · Pro-emetic · ↑CBF, ↑ICP if susceptible · Minimal effect on EEG, can’t be monitored with BIS · Euphoria, abuse potential |
Mutagenesis |
· Oxidises the cobalt atom in Vitamin B12, a cofactor for methionine synthetase · Impaired DNA synthesis · Teratogenesis · Subacute combined degeneration of the cord (chronic abuse) · ? ↑Risk abortion in PACU staff |
Feedback welcome at ketaminenightmares@gmail.com